US loan trading: CLOs treated to DaVita as Refinitiv outflows escalate
US CLO managers were treated to a $2.75 billion term loan B by kidney dialysis services provider DaVita, which became the most popular issuer in August. And Refinitiv US Holdings continued to be the most sold US issuer by CLOs, according to the latest trustee reports from CLO-i
Subscriber-only article
This article is available only to Creditflux subscribers and free trial users within 30 days of publication.
Already a subscriber? Not logged in? Click here to login.
If you have not already done so,
you may request a FREE TRIAL by clicking here
This trial will give you:
- 4-weeks' free online access to our
most recent subscriber-only articles - Daily breaking news alert sent by email
- A print copy of Creditflux
If you currently have a free trial, you will see this message when you try to view articles older than 30 days.
Related Stories
- New short-dated CLO brings triple-As down to 132bps 6 hours ago
- Oaktree makes it two new US CLOs this year 6 hours ago
- Symphony refis triple-As from TIAA’s debut CLO 23 hours ago
- Sound Point refinances triple As of 2020 vintage CLO 23 hours ago
- Strong run helps CLOs shrug off Altice downgrade 23 hours ago
CLOs
- New short-dated CLO brings triple-As down to 132bps 6 hours ago
- Oaktree makes it two new US CLOs this year 6 hours ago
- Symphony refis triple-As from TIAA’s debut CLO 23 hours ago
- Sound Point refinances triple As of 2020 vintage CLO 23 hours ago
- Celebrating Women in CLOs 1 day ago